Alan Pitt, MD is Co-founder and Chief Executive Officer of Vitalchat, a leading-edge telemedicine company delivering hands-free technologies that virtually connect providers, patients and loved ones. His visionary leadership has paved the way for Vitalchat to be the most effective and affordable inpatient solution in the market.
Alan has more than two decades of experience as an esteemed entrepreneur, neuroradiologist and Professor of Neuroradiology at the Barrow Neurological Institute in Phoenix. He has dedicated his life’s work to streamlining the healthcare experience and leveraging collaboration to enhance lifesaving services, human interaction and quality of care.
Working on the frontlines of clinical care, specifically with acutely and chronically ill patients, has given him an insider perspective of efficiency gaps within the healthcare system.
After spearheading a wide range of successful business initiatives in robotics, imaging, artificial intelligence (AI) and telemedicine, Alan helped develop Vitalchat as a next-generation telehealth software maximizing hospital-wide efficiencies, improving response rates and outcomes, and enabling cloud-based resources to address labor demands and costs.
Prior to launching Vitalchat, Alan honed his leadership skills as Chief Medical Officer for Avizia, a telehealth company merged with AmWell. He also co-founded Excelcius Robotics, which was acquired by Globus Medical in 2013.
Heavily involved with his community and multiple healthcare organizations, he currently serves as Chief Medical Officer of clinical AI platform CloudMedX, Key Opinion Leader (KOL) for Precision Diagnostics for Philips Healthcare, Adjunct Faculty for the University of Arizona School of Public Health and a Board Member for Axis for Autism.
With a Bachelor of Arts in Human Biology from Stanford University, Alan earned a medical degree from the University of Arizona, completing training in radiology and neurology at University of Texas Southwestern Medical Center and a fellowship in neuroradiology at Barrow Neurological Institute.
